Journal of Genetic Medicine

Korean Society of Medical Genetics and Genomics (대한의학유전학회)
권호 표지
DOI QR코드

DOI QR Code

Using zebrafish as an animal model for studying rare neurological disorders: A human genetics perspective

  • Dilan Wellalage Don (Department of Biology, Chungnam National University) ;
  • Tae-Ik Choi (Department of Biology, Chungnam National University) ;
  • Tae-Yoon Kim (Department of Biology, Chungnam National University) ;
  • Kang-Han Lee (Department of Biology, Chungnam National University) ;
  • Yoonsung Lee (Clinical Research Institute, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University) ;
  • Cheol-Hee Kim (Department of Biology, Chungnam National University)
  • Received : 2024.05.13
  • Accepted : 2024.06.09
  • Published : 2024.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Rare diseases are characterized by a low prevalence, which often means that patients with such diseases are undiagnosed and do not have effective treatment options. Neurodevelopmental and neurological disorders make up around 40% of rare diseases and in the past decade, there has been a surge in the identification of genes linked to these conditions. This has created the need for model organisms to reveal mechanisms and to assess therapeutic methods. Different model animals have been employed, like Caenorhabditis elegans, Drosophila, zebrafish, and mice, to investigate the rare neurological diseases and to identify the causative genes. While the zebrafish has become a popular animal model in the last decade, mainly for studying brain development, understanding neural circuits, and conducting chemical screens, the mouse has been a very well-known model for decades. This review explores the strengths and limitations of using zebrafish as a vertebrate animal model for rare neurological disorders, emphasizing the features that make this animal model promising for the research on these disorders.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant (RS-2024-00349650).

References

  1. Dawkins HJS, Draghia-Akli R, Lasko P, Lau LPL, Jonker AH, Cutillo CM, et al.; International Rare Diseases Research Consortium (IRDiRC). Progress in rare diseases research 2010-2016: an IRDiRC perspective. Clin Transl Sci 2018;11:11-20.
  2. Wangler MF, Yamamoto S, Chao HT, Posey JE, Westerfield M, Postlethwait J, et al. Model organisms facilitate rare disease diagnosis and therapeutic research. Genetics 2017;207:9-27.
  3. Liu J, Barrett JS, Leonardi ET, Lee L, Roychoudhury S, Chen Y, et al. Natural history and real-world data in rare diseases: applications, limitations, and future perspectives. J Clin Pharmacol 2022;62(Suppl 2):S38-55.
  4. Sakai C, Ijaz S, Hoffman EJ. Zebrafish models of neurodevelopmental disorders: past, present, and future. Front Mol Neurosci 2018;11:294.
  5. Burgess HA, Burton EA. A critical review of zebrafish neurological disease models-1. The premise: neuroanatomical, cellular and genetic homology and experimental tractability. Oxf Open Neurosci 2023;2:kvac018.
  6. Amsterdam A, Becker TS. Transgenes as screening tools to probe and manipulate the zebrafish genome. Dev Dyn 2005;234:255-68.
  7. Son M, Kim DY, Kim CH. Disease modeling of rare neurological disorders in zebrafish. Int J Mol Sci 2022;23:3946.
  8. Choi TY, Choi TI, Lee YR, Choe SK, Kim CH. Zebrafish as an animal model for biomedical research. Exp Mol Med 2021;53:310-7.
  9. Schmidt R, Strahle U, Scholpp S. Neurogenesis in zebrafish - from embryo to adult. Neural Dev 2013;8:3.
  10. Adamson KI, Sheridan E, Grierson AJ. Use of zebrafish models to investigate rare human disease. J Med Genet 2018;55:641-9.
  11. Kim TY, Roychaudhury A, Kim HT, Choi TI, Baek ST, Thyme SB, et al. Impairments of cerebellar structure and function in a zebrafish KO of neuropsychiatric risk gene znf536. Transl Psychiatry 2024;14:82.
  12. Toft M. Advances in genetic diagnosis of neurological disorders. Acta Neurol Scand Suppl 2014;198:20-5.
  13. Wong HH, Seet SH, Maier M, Gurel A, Traspas RM, Lee C, et al. Loss of C2orf69 defines a fatal autoinflammatory syndrome in humans and zebrafish that evokes a glycogen-storage-associated mitochondriopathy. Am J Hum Genet 2021;108:1301-17.
  14. Chong JX, Talbot JC, Teets EM, Previs S, Martin BL, Shively KM, et al. Mutations in MYLPF cause a novel segmental amyoplasia that manifests as distal arthrogryposis. Am J Hum Genet 2020;107:293-310.
  15. Siekierska A, Stamberger H, Deconinck T, Oprescu SN, Partoens M, Zhang Y, et al. Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish. Nat Commun 2019;10:708.
  16. Van Haute L, O'Connor E, Diaz-Maldonado H, Munro B, Polavarapu K, Hock DH, et al. TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease. Nat Commun 2023;14:1009.
  17. Thyme SB, Pieper LM, Li EH, Pandey S, Wang Y, Morris NS, et al. Phenotypic landscape of schizophrenia-associated genes defines candidates and their shared functions. Cell 2019;177:478-91.e20.
  18. Capps MES, Moyer AJ, Conklin CL, Martina V, Torija-Olson EG, Klein MC, et al. Diencephalic and neuropeptidergic dysfunction in zebrafish with autism risk mutations. bioRxiv 2024, in press.
  19. Kim HG, Ahn JW, Kurth I, Ullmann R, Kim HT, Kulharya A, et al. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2010;87:465-79.
  20. Kim HG, Kim HT, Leach NT, Lan F, Ullmann R, Silahtaroglu A, et al. Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. Am J Hum Genet 2012;91:56-72.
  21. May M, Hwang KS, Miles J, Williams C, Niranjan T, Kahler SG, et al. ZC4H2, an XLID gene, is required for the generation of a specific subset of CNS interneurons. Hum Mol Genet 2015;24:4848-61.
  22. Soppa U, Schumacher J, Florencio Ortiz V, Pasqualon T, Tejedor FJ, Becker W. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle 2014;13:2084-100.
  23. Kim OH, Cho HJ, Han E, Hong TI, Ariyasiri K, Choi JH, et al. Zebrafish knockout of Down syndrome gene, DYRK1A, shows social impairments relevant to autism. Mol Autism 2017;8:50.
  24. Choi JH, Jeong YM, Kim S, Lee B, Ariyasiri K, Kim HT, et al. Targeted knockout of a chemokine-like gene increases anxiety and fear responses. Proc Natl Acad Sci U S A 2018;115:E1041-50.
  25. Lee YR, Khan K, Armfield-Uhas K, Srikanth S, Thompson NA, Pardo M, et al. Mutations in FAM50A suggest that Armfield XLID syndrome is a spliceosomopathy. Nat Commun 2020;11:3698.
  26. Lee YR, Kim SH, Ben-Mahmoud A, Kim OH, Choi TI, Lee KH, et al. Eif2b3 mutants recapitulate phenotypes of vanishing white matter disease and validate novel disease alleles in zebrafish. Hum Mol Genet 2021;30:331-42.
  27. Shin U, Choi Y, Ko HS, Myung K, Lee S, Cheon CK, et al. A heterozygous mutation in UBE2H in a patient with developmental delay leads to an aberrant brain development in zebrafish. Hum Genomics 2023;17:44.
  28. Shepherdson JL, Hutchison K, Don DW, McGillivray G, Choi TI, Allan CA, et al. Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt. Am J Hum Genet 2024;111:487-508.
  29. Topf A, Cox D, Zaharieva IT, Di Leo V, Sarparanta J, Jonson PH, et al. Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy. Nat Genet 2024;56:395-407.
  30. Lee YR, Thomas MG, Roychaudhury A, Skinner C, Maconachie G, Crosier M, et al. Eye movement defects in KO zebrafish reveals SRPK3 as a causative gene for an X-linked intellectual disability. Res Sq 2023, in press.